METTL14-mediated m6A epitranscriptomic modification contributes to chemotherapy-induced neuropathic pain by stabilizing GluN2A expression via IGF2BP2.
Lu W, Yang X, Zhong W, Chen G, Guo X, Ye Q, Xu Y, Qi Z, Ye Y, Zhang J, Wang Y, Wang X, Wang S, Zhao Q, Zeng W, Huang J, Ma H, Xie J.
Lu W, et al. Among authors: zeng w.
J Clin Invest. 2024 Feb 6;134(6):e174847. doi: 10.1172/JCI174847.
J Clin Invest. 2024.
PMID: 38319733
Free PMC article.